Rigel Pharmaceuticals
RIGL
#7539
Rank
S$0.40 B
Marketcap
$23.15
Share price
-0.70%
Change (1 day)
38.52%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): S$14.79 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are S$0.15 Billion. In 2023 the company made an earning of -S$24.69 Million, an increase over its 2022 earnings that were of -S$74.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$14.79 M-159.94%
2023 -S$24.69 Million-66.79%
2022 -S$74.33 Million340.73%
2021 -S$16.87 Million-56.15%
2020 -S$38.47 Million-57.34%
2019 -S$90.17 Million-7.66%
2018 -S$97.65 Million-9.47%
2017 -S$0.11 Billion24.46%
2016 -S$86.67 Million23.63%
2015 -S$70.1 Million-43.29%
2014 -S$0.13 Billion2.5%
2013 -S$0.13 Billion
2010 S$51.28 M-133.97%
2009 -S$0.16 Billion-18.49%
2008 -S$0.19 Billion71.91%
2007 -S$0.11 Billion84.74%
2006 -S$58.32 Million-10.17%
2005 -S$64.92 Million-15.73%
2004 -S$77.04 Million39.29%
2003 -S$55.31 Million10.3%
2002 -S$50.15 Million48.3%
2001 -S$33.82 Million-2.13%
2000 -S$34.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.18 Billion-1,211.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.19 Billion-1,242.21%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.06 B 81,961.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$6.33 B 39,717.89%๐Ÿ‡บ๐Ÿ‡ธ USA